|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Danco Laboratories Alerts Doctors To Five Deaths
10/19/2005 5:10:48 PM
Five women who took the abortion pill RU-486 have died from bacterial infections since its U.S. introduction nearly five years ago, the manufacturer reported on Monday.
"No causal relationship between these events" has been established with the drug, also known as Mifeprex or mifepristone, maker Danco Laboratories LLC said.
"Childbirth, menstruation and abortion, whether spontaneous, surgical or medical, all create conditions that can result in serious and sometimes fatal infection, and there is no evidence that Mifeprex and misoprostol present a special risk of infection," the company said in a statement.
Misoprostol is a drug that women must take two days after Mifeprex to complete the abortion.
Danco said it was sending a letter to alert physicians about the cases and updating warning information on the drug's label.
Mifeprex already carries a warning about the possibility that women who take the drug could experience serious and sometimes fatal infections. The company is updating the label to give physicians more information to help them spot the problem, Danco spokeswoman Cynthia Summers said.
|
|
|
|
|
|
|
|
|
|
|